Literature DB >> 3599999

Left ventricular dysfunction and dilatation resulting from chronic supraventricular tachycardia.

R J Damiano, H F Tripp, T Asano, K W Small, R H Jones, J E Lowe.   

Abstract

It has been suggested that patients with chronic supraventricular tachycardia may have impaired ventricular function, which returns to normal after surgical procedures that eliminate the tachycardia. The purpose of this study was to determine the functional consequences of prolonged supraventricular tachycardia in 12 awake dogs in which permanent asynchronous atrial pacemakers were implanted and programmed to a rate of 190 +/- 5 beats/min. Serial radionuclide angiograms were obtained immediately after pacemaker activation and at regular intervals over a 3 month period. Chronic tachycardia resulted in a significantly depressed ejection fraction (49% +/- 1% to 29% +/- 3%; p less than 0.0005) compensated for by a dramatic increase in left ventricular end-diastolic volume (69 +/- 4 to 105 +/- 9 ml, p less than 0.005). Stroke volume and cardiac output were not significantly changed. Five dogs were allowed to recover, and serial radionuclide angiograms were obtained for 12 weeks. Although ejection fraction returned to control values (50% versus 47%, p = no significant difference), end-diastolic volume remained persistently elevated after a 12 week recovery period in all animals (67 +/- 5 versus 91 +/- 6 ml, p less than 0.05). Thus prolonged tachycardia resulted in significant functional changes associated with cardiac enlargement, which were not immediately reversible.

Entities:  

Mesh:

Year:  1987        PMID: 3599999

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  12 in total

1.  Predictors of ECMO support in infants with tachycardia-induced cardiomyopathy.

Authors:  Jack Christian Salerno; Stephen Paul Seslar; Terrence Ung Hoong Chun; Mina Vafaeezadeh; Andrea Rae Parrish; Lester Cal Permut; Gordon Alan Cohen; David Michael McMullan
Journal:  Pediatr Cardiol       Date:  2011-03-30       Impact factor: 1.655

2.  Alterations in the myocardial capillary vasculature accompany tachycardia-induced cardiomyopathy.

Authors:  F G Spinale; R C Grine; G E Tempel; F A Crawford; M R Zile
Journal:  Basic Res Cardiol       Date:  1992 Jan-Feb       Impact factor: 17.165

3.  Recovery pattern of left ventricular dysfunction following radiofrequency ablation of incessant supraventricular tachycardia in infants and children.

Authors:  J V De Giovanni; A Dindar; M J Griffith; R A Edgar; E D Silove; O Stumper; J G Wright
Journal:  Heart       Date:  1998-06       Impact factor: 5.994

4.  Prospective study of left ventricular function after radiofrequency ablation of atrioventricular junction in patients with atrial fibrillation.

Authors:  M Edner; K Caidahl; L Bergfeldt; B Darpö; N Edvardsson; M Rosenqvist
Journal:  Br Heart J       Date:  1995-09

5.  Altered calsequestrin glycan processing is common to diverse models of canine heart failure.

Authors:  Sony Jacob; Naama H Sleiman; Stephanie Kern; Larry R Jones; Javier A Sala-Mercado; Timothy P McFarland; Hani H Sabbah; Steven E Cala
Journal:  Mol Cell Biochem       Date:  2013-03-01       Impact factor: 3.396

6.  Chronic inappropriate sinus tachycardia in elderly females.

Authors:  Gustavo Lopera; Agustin Castellanos; Federico Moleiro; Heikki V Huikuri; Robert J Myerburg
Journal:  Ann Noninvasive Electrocardiol       Date:  2003-04       Impact factor: 1.468

Review 7.  Comorbidity of atrial fibrillation and heart failure.

Authors:  Liang-Han Ling; Peter M Kistler; Jonathan M Kalman; Richard J Schilling; Ross J Hunter
Journal:  Nat Rev Cardiol       Date:  2015-12-10       Impact factor: 32.419

Review 8.  Heart failure and tachycardia-induced cardiomyopathy.

Authors:  Ethan R Ellis; Mark E Josephson
Journal:  Curr Heart Fail Rep       Date:  2013-12

9.  Surgical management of dysrhythmias in infants and small children.

Authors:  F A Crawford; P C Gillette; C L Case; V Zeigler
Journal:  Ann Surg       Date:  1992-09       Impact factor: 12.969

10.  What About Tachycardia-induced Cardiomyopathy?

Authors:  Ethan R Ellis; Mark E Josephson
Journal:  Arrhythm Electrophysiol Rev       Date:  2013-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.